A new drug could save 25 000 women living with HIV but could it come at the cost of their babies lives?
An international drug maker may have intentionally muscled out local competition to win the bulk of a national birth control tender.
Maternal deaths in developing regions would fall by 73% if all women had access to contraception and maternal healthcare, shows new research.
Governments and even anonymous do-gooders are stepping into fill the funding gap left by the US decision, but their pockets will never be deep enough.
This implant offers all the protection from unwanted pregnancies with almost none of the clinic visits. So why did many say, ‘thanks, but no thanks’?